CHEOY:OTCMKTS
Cochlear Ord ADR
44,72 US$
arrow_downward
-0,07%(-0,030) 1D
15 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për CHEOY...
Hap
44,61 US$
I lartë
44,82 US$
I ulët
44,60 US$
Kapitalizimi i tregut
8,58 mld
Vëllimi mesatar
18,50 mijë
Vëllimi
26,66 mijë
Maksimumi 52-javor
98,49 US$
Minimumi 52-javor
31,82 US$
Beta
0,68
Aksionet në qarkullim
130,80 mln
Numri i punonjësve
5 mijë
Hap
44,61 US$
I lartë
44,82 US$
I ulët
44,60 US$
Kapitalizimi i tregut
8,58 mld
Vëllimi mesatar
18,50 mijë
Vëllimi
26,66 mijë
Maksimumi 52-javor
98,49 US$
Minimumi 52-javor
31,82 US$
Beta
0,68
Aksionet në qarkullim
130,80 mln
Numri i punonjësve
5 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Simply Wall Street
·
16 orë më parë
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
1 ditë më parë
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profili
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Rreth Cochlear Ord ADR
Drejtori ekzekutivDig Howitt
Punonjësit5,4 mijë
Themeluar më1981
SeliaSidnei, Uellsi i Ri Jugor, Australi
SektoriMedical device
Uebsajticochlear.com